The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
CorrectionFull Access

Correction

Published Online:https://doi.org/10.1176/ajp.159.6.1076

In the letter by John P. O’Reardon, M.D., et al. titled “Desipramine Toxicity With Terbinafine” (Am J Psychiatry 2002; 159:492), the first sentence in the next-to-last paragraph should read, “After a single 250-mg dose of terbinafine, the elimination half-life is 16–100 hours; after 4 weeks of terbinafine, 250 mg/day, the mean plasma half-life is 22 days (3).”